Standard BioTools Inc., together with its subsidiaries, provides instruments, consumables, reagents, and software services for researchers and clinical laboratories in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operates through two segments: Proteomics and Genomics. It provides SomaScan platform that enables researchers to measure thousands of proteins simultaneously, providing deep insights into biological processes and disease mechanism; CyTOF technology platform that uses metal-tagged antibodies and time-of-flight mass spectrometry to eliminate signal interference and expand multiplexing capabilities; Hyperion, a spatial biology platform unlocks deeper insights into tissue organization by preserving spatial context while enabling high-dimensional molecular and proteomic analysis; and Biomark X9 system redefines high-throughput genomics by delivering exceptional efficiency, precision, and scalability for qPCR applications. It sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations. It has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in April 2022. Fluidigm Corporation was incorporated in 1999 and is headquartered in South San Francisco, California.

Standard BioTools Inc.

Silicon Laboratories (SLAB) Gets a Hold from Barclays

Barclays Sticks to Their Hold Rating for Astera Labs, Inc. (ALAB)

There’s a lot to be optimistic about in the Technology sector as 3 analysts just weighed in on Vuzix (VUZI – Research Report), Broadcom (AVGO – Res...

Analysts Are Bullish on Top Technology Stocks: Vuzix (VUZI), Broadcom (AVGO)

Labrador Gold Corp ( ($TSE:LAB) ) has provided an update. Labrador Gold Corp has announced a strategic shift to become a hybrid mining and investme...

Labrador Gold Corp Announces Strategic Shift to Hybrid Mining and Investment Model

The latest update is out from MediPharm Labs ( ($TSE:LABS) ). MediPharm Labs has completed its first shipment to France, marking a significant mile...

MediPharm Labs Enters French Medicinal Cannabis Market with First Shipment

There’s a lot to be optimistic about in the Technology sector as 3 analysts just weighed in on Veeco (VECO – Research Report), Astera Labs, Inc. (A...

Analysts Are Bullish on These Technology Stocks: Veeco (VECO), Astera Labs, Inc. (ALAB)

In a report released today, Vivek Arya from Bank of America Securities maintained a Hold rating on Astera Labs, Inc., with a price target of $210.0...

Astera Labs, Inc. (ALAB) Receives a Hold from Bank of America Securities

Barclays Keeps Their Hold Rating on Astera Labs, Inc. (ALAB)

Looking Glass Labs Ltd. ( ($TSE:LABZ) ) has shared an announcement. Metasphere Labs Inc. has announced the cancellation of its non-brokered LIFE Of...

Metasphere Labs Cancels LIFE Offering Amid Market Challenges

MediPharm Labs ( ($TSE:LABS) ) has provided an update. MediPharm Labs announced the complete dismissal of a defamation action initiated by Apollo, ...

Current Quarter	$NA	Next Quarter	$NA
Current Year	$NA	Next Year	$NA
QoQ Growth	NaN%	YoY Growth	NaN%
3Y EPS CAGR	+12.6%	Target Price	$1.55
Consensus	Buy	Upside	+6.9%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	LAB	$1.45	-2.03%	958.39K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	LAB	$1.45	-2.0%	958.39K
3
4
5
6

LAB

LAB

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Standard BioTools Inc. Data in Excel

Get Standard BioTools Inc. Data in Excel